Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H(HK:1858)
HK$7.27-0.15 (-1.96%)
HK:1858
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H financials statements
HK$7.27
At close:-0.15 (-1.96%)
Want to see HK:1858 full AI Analyst Report?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Ratios
0 Followers
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Ratios
HK:1858's free cash flow for Q3 2026 was ¥79.37M. For the 2026 fiscal year, HK:1858's free cash flow was decreased by ¥-4.25M and operating cash flow was ¥83.62M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.20 | 5.20 | 4.44 | 4.66 | 5.57 |
| Quick Ratio | 4.28 | 4.19 | 3.80 | 4.23 | 5.20 |
| Cash Ratio | 2.44 | 2.08 | 1.87 | 1.61 | 3.95 |
| Solvency Ratio | 0.47 | 0.25 | 0.41 | 0.49 | 0.64 |
| Operating Cash Flow Ratio | 0.71 | -0.00 | 0.76 | 0.07 | 0.37 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 2.34B | ¥ 2.20B | ¥ 2.24B | ¥ 2.09B | ¥ 1.92B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.23 | 1.23 | 1.27 | 1.25 | 1.21 |
| Debt Service Coverage Ratio | 1406.27 | 3613.41 | 856.65 | 7229.52 | 1231.62 |
| Interest Coverage Ratio | 1504.11 | 2908.71 | 838.61 | 7039.25 | 1432.83 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 |
| Net Debt to EBITDA | -4.51 | -6.73 | -3.71 | -2.60 | -4.81 |
| Profitability Margins | |||||
| Gross Profit Margin | 62.48% | 64.09% | 72.48% | 76.03% | 77.11% |
| EBIT Margin | 25.84% | 16.34% | 25.32% | 28.04% | 31.08% |
| EBITDA Margin | 29.80% | 21.01% | 28.19% | 30.54% | 32.58% |
| Operating Profit Margin | 28.90% | 16.22% | 25.32% | 27.37% | 33.17% |
| Pretax Profit Margin | 28.85% | 16.33% | 25.31% | 28.04% | 33.15% |
| Net Profit Margin | 26.06% | 15.51% | 22.99% | 25.61% | 29.09% |
| Continuous Operations Profit Margin | 26.07% | 15.47% | 22.99% | 25.61% | 29.09% |
| Net Income Per EBT | 90.33% | 94.98% | 90.82% | 91.34% | 87.75% |
| EBT Per EBIT | 99.82% | 100.68% | 99.98% | 102.42% | 99.94% |
| Return on Assets (ROA) | 7.44% | 3.61% | 7.61% | 9.02% | 10.75% |
| Return on Equity (ROE) | 9.13% | 4.43% | 9.66% | 11.31% | 13.06% |
| Return on Capital Employed (ROCE) | 9.80% | 4.48% | 10.29% | 11.69% | 14.36% |
| Return on Invested Capital (ROIC) | 8.85% | 4.24% | 9.34% | 10.67% | 12.59% |
| Return on Tangible Assets | 7.69% | 3.74% | 7.94% | 9.41% | 11.24% |
| Earnings Yield | 5.33% | 4.11% | 6.69% | 5.69% | 7.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.52 | 2.03 | 2.74 | 1.57 | 2.10 |
| Payables Turnover | 2.44 | 1.27 | 1.48 | 1.21 | 3.27 |
| Inventory Turnover | 0.73 | 0.53 | 0.77 | 1.11 | 1.59 |
| Fixed Asset Turnover | 2.15 | 1.72 | 2.60 | 2.58 | 2.81 |
| Asset Turnover | 0.29 | 0.23 | 0.33 | 0.35 | 0.37 |
| Working Capital Turnover Ratio | 0.44 | 0.35 | 0.54 | 0.57 | 0.77 |
| Cash Conversion Cycle | 429.95 | 586.86 | 362.73 | 260.98 | 291.89 |
| Days of Sales Outstanding | 80.82 | 179.44 | 133.41 | 233.10 | 173.84 |
| Days of Inventory Outstanding | 498.76 | 694.81 | 476.76 | 329.16 | 229.82 |
| Days of Payables Outstanding | 149.62 | 287.39 | 247.44 | 301.28 | 111.78 |
| Operating Cycle | 579.58 | 874.25 | 610.17 | 562.26 | 403.66 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.07 | -0.01 | 1.33 | 0.11 | 0.48 |
| Free Cash Flow Per Share | 0.92 | -0.13 | 1.24 | 0.04 | -0.10 |
| Dividend Paid and CapEx Coverage Ratio | 2.66 | -0.01 | 3.34 | 0.55 | 0.83 |
| Capital Expenditure Coverage Ratio | 7.11 | -0.04 | 15.39 | 1.65 | 0.83 |
| Operating Cash Flow Coverage Ratio | 125.05 | -2.19 | 291.92 | 31.20 | 134.36 |
| Operating Cash Flow to Sales Ratio | 0.39 | -0.00 | 0.42 | 0.03 | 0.15 |
| Free Cash Flow Yield | 6.88% | -1.68% | 11.52% | 0.30% | -0.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.80 | 24.31 | 14.95 | 17.57 | 13.26 |
| Price-to-Sales (P/S) Ratio | 4.89 | 3.77 | 3.44 | 4.50 | 3.86 |
| Price-to-Book (P/B) Ratio | 1.71 | 1.08 | 1.44 | 1.99 | 1.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.53 | -59.48 | 8.68 | 335.68 | -123.44 |
| Price-to-Operating Cash Flow Ratio | 12.49 | -1599.26 | 8.12 | 131.82 | 25.94 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | -0.45 | -1.50 | -1.26 | 0.99 |
| Enterprise Value Multiple | 11.90 | 11.22 | 8.48 | 12.13 | 7.03 |
| Enterprise Value | 3.71B | 1.90B | 2.89B | 4.45B | 2.54B |
| EV to EBITDA | 11.90 | 11.22 | 8.48 | 12.13 | 7.03 |
| EV to Sales | 3.55 | 2.36 | 2.39 | 3.70 | 2.29 |
| EV to Free Cash Flow | 10.54 | -37.18 | 6.04 | 276.32 | -73.32 |
| EV to Operating Cash Flow | 9.06 | -999.69 | 5.65 | 108.51 | 15.41 |
| Tangible Book Value Per Share | 7.48 | 7.11 | 7.07 | 6.73 | 6.74 |
| Shareholders’ Equity Per Share | 7.79 | 7.45 | 7.46 | 7.09 | 7.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.10 | 0.05 | 0.09 | 0.09 | 0.12 |
| Revenue Per Share | 2.73 | 2.13 | 3.13 | 3.13 | 3.20 |
| Net Income Per Share | 0.71 | 0.33 | 0.72 | 0.80 | 0.93 |
| Tax Burden | 0.90 | 0.95 | 0.91 | 0.91 | 0.88 |
| Interest Burden | 1.12 | 1.00 | 1.00 | 1.00 | 1.07 |
| Research & Development to Revenue | 0.11 | 0.17 | 0.13 | 0.14 | 0.09 |
| SG&A to Revenue | 0.13 | 0.35 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.54 | -0.02 | 1.84 | 0.13 | 0.51 |
Currency in CNY
